BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 16836667)

  • 1. Familial pseudo-Wolff-Parkinson-White syndrome.
    Sternick EB; Oliva A; Magalhães LP; Gerken LM; Hong K; Santana O; Brugada P; Brugada J; Brugada R
    J Cardiovasc Electrophysiol; 2006 Jul; 17(7):724-32. PubMed ID: 16836667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transgenic mice overexpressing mutant PRKAG2 define the cause of Wolff-Parkinson-White syndrome in glycogen storage cardiomyopathy.
    Arad M; Moskowitz IP; Patel VV; Ahmad F; Perez-Atayde AR; Sawyer DB; Walter M; Li GH; Burgon PG; Maguire CT; Stapleton D; Schmitt JP; Guo XX; Pizard A; Kupershmidt S; Roden DM; Berul CI; Seidman CE; Seidman JG
    Circulation; 2003 Jun; 107(22):2850-6. PubMed ID: 12782567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Constitutively active AMP kinase mutations cause glycogen storage disease mimicking hypertrophic cardiomyopathy.
    Arad M; Benson DW; Perez-Atayde AR; McKenna WJ; Sparks EA; Kanter RJ; McGarry K; Seidman JG; Seidman CE
    J Clin Invest; 2002 Feb; 109(3):357-62. PubMed ID: 11827995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Same genotype and different phenotypes in a family with PRKAG2 gene mutation].
    Hong K; Oliva A; Cheng XS; Brugada P; Brugada J; Sternick EB; Brugada R
    Zhonghua Xin Xue Guan Bing Za Zhi; 2007 Jun; 35(6):552-4. PubMed ID: 17711718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycogen storage diseases presenting as hypertrophic cardiomyopathy.
    Arad M; Maron BJ; Gorham JM; Johnson WH; Saul JP; Perez-Atayde AR; Spirito P; Wright GB; Kanter RJ; Seidman CE; Seidman JG
    N Engl J Med; 2005 Jan; 352(4):362-72. PubMed ID: 15673802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A familial form of conduction defect related to a mutation in the PRKAG2 gene.
    Charron P; Genest M; Richard P; Komajda M; Pochmalicki G
    Europace; 2007 Aug; 9(8):597-600. PubMed ID: 17483151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High risk of sudden death associated with a PRKAG2-related familial Wolff-Parkinson-White syndrome.
    Zhang LP; Hui B; Gao BR
    J Electrocardiol; 2011; 44(4):483-6. PubMed ID: 20381067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Familial Atrial Enlargement, Conduction Disorder and Symmetric Cardiac Hypertrophy Are Early Signs of PRKAG2 R302Q.
    Hu J; Tang B; Wang J; Huang K; Wang Y; Lu S; Gowreesunkur HB; Wang Y; Wu D; Mayala HA; Wang ZH
    Curr Med Sci; 2020 Jun; 40(3):486-492. PubMed ID: 32681253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nodoventricular accessory pathways in PRKAG2-dependent familial preexcitation syndrome reveal a disorder in cardiac development.
    Tan HL; van der Wal AC; Campian ME; Kruyswijk HH; ten Hove Jansen B; van Doorn DJ; Oskam HJ; Becker AE; Wilde AA
    Circ Arrhythm Electrophysiol; 2008 Oct; 1(4):276-81. PubMed ID: 19808419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comment on "Familial pseudo-Wolff-Parkinson-White syndrome".
    Green M; Gollob M
    J Cardiovasc Electrophysiol; 2006 Dec; 17(12):E9; author reply E10. PubMed ID: 17096658
    [No Abstract]   [Full Text] [Related]  

  • 11. Novel PRKAG2 mutation responsible for the genetic syndrome of ventricular preexcitation and conduction system disease with childhood onset and absence of cardiac hypertrophy.
    Gollob MH; Seger JJ; Gollob TN; Tapscott T; Gonzales O; Bachinski L; Roberts R
    Circulation; 2001 Dec; 104(25):3030-3. PubMed ID: 11748095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Familial Wolff-Parkinson-White Syndrome: a disease of glycogen storage or ion channel dysfunction?
    Light PE
    J Cardiovasc Electrophysiol; 2006 May; 17 Suppl 1():S158-S161. PubMed ID: 16686673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coexistence of the Wolff-Parkinson-White preexcitation syndrome and complete atrioventricular block.
    Johnson CD
    Bol Asoc Med P R; 2007; 99(3):263-9. PubMed ID: 19610584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular genetic analysis of PRKAG2 in sporadic Wolff-Parkinson-White syndrome.
    Vaughan CJ; Hom Y; Okin DA; McDermott DA; Lerman BB; Basson CT
    J Cardiovasc Electrophysiol; 2003 Mar; 14(3):263-8. PubMed ID: 12716108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pseudo myocardial infarction and pseudo ventricular hypertrophy ECG patterns in Wolff-Parkinson-White syndrome.
    Khan IA; Shaw IS
    Am J Emerg Med; 2000 Nov; 18(7):802-6. PubMed ID: 11103732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A familial form of conduction defects associated with a PRKAG2 gene mutation].
    Pochmalicki G; Genest M; Richard P; Komajda M; Charron P
    Arch Mal Coeur Vaiss; 2007 Sep; 100(9):760-5. PubMed ID: 18033003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CRISPR correction of the PRKAG2 gene mutation in the patient's induced pluripotent stem cell-derived cardiomyocytes eliminates electrophysiological and structural abnormalities.
    Ben Jehuda R; Eisen B; Shemer Y; Mekies LN; Szantai A; Reiter I; Cui H; Guan K; Haron-Khun S; Freimark D; Sperling SR; Gherghiceanu M; Arad M; Binah O
    Heart Rhythm; 2018 Feb; 15(2):267-276. PubMed ID: 28917552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alport syndrome. Molecular genetic aspects.
    Hertz JM
    Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Inheritance of Wolff-Parkinson-White syndrome and evolution of its clinical symptoms in families of patients in a prospective trial].
    Fomina IG; Logunova LV; Kuleshov NP; Markova ZS
    Klin Med (Mosk); 2001; 79(3):26-30. PubMed ID: 11490411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Familial Wolff-Parkinson-White syndrome is linked to the loci on chromosome 7q3.
    Liu W; Liu G; Hu D; Qi Y; Shan Z; Yang D; Liu D; Wang Y
    Chin Med J (Engl); 2002 Nov; 115(11):1733-5. PubMed ID: 12609097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.